Search Within

Pedram Razavi

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (24)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Breast Medicine Service (59)
  2. Department of Medicine (59)
  3. Population Sciences Research Program (59)
  4. Solid Tumor Oncology Division (59)
  5. Weinberg Fellows (59)
  6. GSK Faculty (56)

More Groups

People
  1. Mark Robson (32)
  2. Jorge Reis-Filho (27)
  3. Sarat Chandarlapaty (27)
  4. David Solit (23)
  5. Michael Berger (22)
  6. Ronglai Shen (21)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (3)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Cancer Research (7)
  3. Annals of Oncology (4)
  4. International Journal of Radiation Oncology, Biology, Physics (4)
  5. Nature Medicine (4)
  6. Cancer Discovery (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. American Association for Cancer Research (11)
  3. Nature Publishing Group (10)
  4. Elsevier Inc. (6)
  5. Cell Press (4)
  6. Oxford University Press (4)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
    Meeting Abstract

    Cabel, L.; An, J. A. R.; Kurtz, D.; Ross, D.; Dikoglu, E.; Chen, Y.; Murphy, K.; Szuhany, K.; Stowell, S. L.; Maloney, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Advancing global health equity in oncology clinical trial access
    Editorial

    Bloomberg New Economy International Cancer Coalition; McKinsey Cancer Center; Cure4Cancer
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
    Journal Article

    Mai, N.; dos Anjos, C. H.; Razavi, P.; Safonov, A.; Patil, S.; Chen, Y.; Drago, J. Z.; Modi, S.; Bromberg, J. F.; Dang, C. T.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism
    Journal Article

    Jee, J.; Brannon, A. R.; Singh, R.; Derkach, A.; Fong, C.; Lee, A.; Gray, L.; Pichotta, K.; Luthra, A.; Diosdado, M.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US
    Meeting Abstract

    Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save